Heroin use is associated with suppressed Pro-inflammatory cytokine response after LPS exposure in HIV-infected individuals

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Meijerink, Hinta ^a   Indrati, Agnes ^b   Utami, Fitri ^b   Soedarmo, Suharyani ^b   Alisjahbana, Bachti ^b   Netea, Mihai G ^a   Van Crevel, Reinout ^a   Wisaksana, Rudi ^b   Van Der Ven, Andre Jam ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hasan Sadikin Hospital   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; CYTOKINE; DIAMORPHINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; METHADONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CANDIDA ALBICANS; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DOWN REGULATION; EX VIVO STUDY; FEMALE; HEROIN DEPENDENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INDONESIA; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPIATE SUBSTITUTION TREATMENT; PROTEIN ANALYSIS; IMMUNOLOGY; YOUNG ADULT;

CANDIDA ALBICANS; MYCOBACTERIUM TUBERCULOSIS;

ADULT; CYTOKINES; FEMALE; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MALE; YOUNG ADULT;

EID: 84926490154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122822     Document Type: Article

References (65)

1. Finley MJ, Happel CM, Kaminsky DE, Rogers TJ Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression. Cell Immunol 2008; 252: 146-154. doi: 10.1016/j.cellimm.2007.09. 008 PMID: 18279847
2. Kapadia F, Vlahov D, Donahoe RM, Friedland G The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis 2005; 41: 1027-1034. PMID: 16142670
3. Wang J, Barke RA, Ma J, Charboneau R, Roy S Opiate abuse, innate immunity, and bacterial infectious diseases. Arch Immunol Ther Exp 2008; 56: 299-309. doi: 10.1007/s00005-008-0035-0 PMID: 18836861
4. Donahoe RM, Vlahov D Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 1998; 83: 77-87. PMID: 9610676
5. Steele AD, Henderson EE, Rogers TJ Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 2003; 309: 99-107. PMID: 12726730
6. Friedman H, Pross S, Klein TW Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol 2006; 47: 330-342. PMID: 16872369
7. Roy S, Ninkovic J, Banerjee S, Charboneau RG, Das S, Dutta R, et al. Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections. J Neuroimmune Pharmacol 2011; 6: 442-465. doi: 10.1007/s11481-011-9292-5 PMID: 21789507
8. Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, et al. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 2002; 31 Suppl 2: S62-69. PMID: 12394784
9. Mathews PM, Froelich CJ, Sibbitt WL Jr., Bankhurst AD Enhancement of natural cytotoxicity by betaendorphin. J Immunol 1983; 130: 1658-1662. PMID: 6300232
10. Mandler RN, Biddison WE, Mandler R, Serrate SA beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol 1986; 136: 934-939. PMID: 2934481
11. Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF Opioid-mediated suppression of interferongamma production by cultured peripheral blood mononuclear cells. J Clin Invest 1987; 80: 824-831. PMID: 3040807
12. Andjelkov N, Elvenes J, Martin J, Johansen O Opiate regulation of IL-1beta and TNF-alpha in cultured human articular chondrocytes. Biochem Biophys Res Commun 2005; 333: 1295-1299. PMID: 15979578
13. Bastami S, Norling C, Trinks C, Holmlund B, Walz TM, Ahlner J, et al. Inhibitory effect of opiates on LPS mediated release of TNF and IL-8. Acta Oncol 2013; 52: 1022-1033. doi: 10.3109/0284186X.2012. 737932 PMID: 23145506
14. Bhargava HN, Thomas PT, Thorat S, House RV Effects of morphine tolerance and abstinence on cellular immune function. Brain Res 1994; 642: 1-10. PMID: 8032870
15. Bonnet MP, Beloeil H, Benhamou D, Mazoit JX, Asehnoune K The mu opioid receptor mediates mor-phine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth Analg 2008; 106: 1142-1149, table of contents. doi: 10.1213/ane.0b013e318165de89 PMID: 18349186
16. Chao CC, Molitor TW, Close K, Hu S, Peterson PK Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int J Immunopharmacol 1993; 15: 447-453. PMID: 8389331
17. Lorenzo P, Portoles A Jr., Beneit JV, Ronda E, Portoles A Physical dependence to morphine diminishes the interferon response in mice. Immunopharmacology 1987; 14: 93-99. PMID: 2448267
18. Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 1993; 265: 1071-1078. PMID: 7685383
19. Gein SV, Gorshkova KG, Tendryakova SP Regulation of interleukin-1beta and interleukin-8 production by agonists of mu and delta opiate receptors in vitro. Neurosci Behav Physiol 2009; 39: 591-595. doi: 10.1007/s11055-009-9166-y PMID: 19513849
20. Yokota T, Uehara K, Nomoto Y Addition of noradrenaline to intrathecal morphine augments the postoperative suppression of natural killer cell activity. J Anesth 2004; 18: 190-195. PMID: 15290418
21. Beilin B, Shavit Y, Trabekin E, Mordashev B, Mayburd E, Zeidel A, et al. The effects of postoperative pain management on immune response to surgery. Anesth Analg 2003; 97: 822-827. PMID: 12933409
22. Sacerdote P, Bianchi M, Gaspani L, Manfredi B, Maucione A, Terno G, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 2000; 90: 1411-1414. PMID: 10825330
23. Wang ZY, Wang CQ, Yang JJ, Sun J, Huang YH, Tang QF, et al. Which has the least immunity depression during postoperative analgesia-morphine, tramadol, or tramadol with lornoxicam? Clin Chim Acta 2006; 369: 40-45. PMID: 16487501
24. Hashiguchi S, Morisaki H, Kotake Y, Takeda J Effects of morphine and its metabolites on immune function in advanced cancer patients. J Clin Anesth 2005; 17: 575-580. PMID: 16427525
25. Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, Weiss J, et al. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995; 83: 500-508. PMID: 7661350
26. Carmody JJ Opiate receptors: an introduction. Anaesth Intensive Care 1987; 15: 27-37. PMID: 3032015
27. Fowler CJ, Fraser GL Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem Int 1994; 24: 401-426. PMID: 7647696
28. Drake CT, Chavkin C, Milner TA Opioid systems in the dentate gyrus. Prog Brain Res 2007; 163: 245-263. PMID: 17765723
29. Neri S, Bruno CM, Pulvirenti D, Malaguarnera M, Italiano C, Mauceri B, et al. Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers. Psychopharmacology (Berl) 2005; 179: 700-704. PMID: 15806416
30. Azarang A, Mahmoodi M, Rajabalian S, Shekari MA, Nosratabadi J, Rezaei N T-helper 1 and 2 serum cytokine assay in chronic opioid addicts. Eur Cytokine Netw 2007; 18: 210-214. PMID: 17993452
31. Wisaksana R, Indrati AK, Fibriani A, Rogayah E, Sudjana P, Djajakusumah TS, et al. Response to firstline antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Addiction 2010; 105: 1055-1061. doi: 10.1111/j.1360-0443. 2010.02898.x PMID: 20331555
32. Zhang Y, Li H, Li Y, Sun X, Zhu M, Hanley G, et al. Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice. Neurosci Lett 2011; 489: 43-47. doi: 10.1016/j.neulet.2010.11.063 PMID: 21130144
33. Dutta R, Krishnan A, Meng J, Das S, Ma J, Banerjee S, et al. Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae. J Neurosci 2012; 32: 9917-9930. doi: 10.1523/JNEUROSCI.0870-12.2012 PMID: 22815507
34. Wang J, Ma J, Charboneau R, Barke R, Roy S Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling. J Biol Chem 2011; 286: 10225-10232. doi: 10. 1074/jbc.M110.188680 PMID: 21245149
35. Wang X, Loram LC, Ramos K, de Jesus AJ, Thomas J, Cheng K, et al. Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci U S A 2012; 109: 6325-6330. doi: 10. 1073/pnas.1200130109 PMID: 22474354
36. Schwarz JM, Bilbo SD Adolescent morphine exposure affects long-term microglial function and laterlife relapse liability in a model of addiction. J Neurosci 2013; 33: 961-971. doi: 10.1523/JNEUROSCI. 2516-12.2013 PMID: 23325235
37. Franchi S, Moretti S, Castelli M, Lattuada D, Scavullo C, Panerai AE, et al. Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages. Brain Behav Immun 2012; 26: 480-488. doi: 10.1016/j.bbi.2011.12.010 PMID: 22240038
38. Stevens CW, Aravind S, Das S, Davis RL Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4. Br J Pharmacol 2013; 168: 1421-1429. doi: 10.1111/bph.12028 PMID: 23083095
39. Madera-Salcedo IK, Cruz SL, Gonzalez-Espinosa C Morphine prevents lipopolysaccharide-induced TNF secretion in mast cells blocking IkappaB kinase activation and SNAP-23 phosphorylation: correlation with the formation of a beta-arrestin/TRAF6 complex. J Immunol 2013; 191: 3400-3409. doi: 10. 4049/jimmunol.1202658 PMID: 23960234
40. Sauer RS, Hackel D, Morschel L, Sahlbach H, Wang Y, Mousa SA, et al. Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation. Mol Pain 2014; 10: 10. doi: 10.1186/1744-8069-10-10 PMID: 24499354
41. Eidson LN, Murphy AZ Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine. J Neurosci 2013; 33: 15952-15963. doi: 10.1523/ JNEUROSCI.1609-13.2013 PMID: 24089500
42. Theberge FR, Li X, Kambhampati S, Pickens CL, St Laurent R, Bossert JM, et al. Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. Biol Psychiatry 2013; 73: 729-737. doi: 10.1016/j.biopsych.2012.12.019 PMID: 23384483
43. Mattioli TA, Leduc-Pessah H, Skelhorne-Gross G, Nicol CJ, Milne B, Trang T, et al. Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence. PLoS One 2014; 9: e97361. doi: 10.1371/journal.pone.0097361 PMID: 24824631
44. Kueppers PM, Miller TA, Chen CY, Smith GS, Rodriguez LF, Moody FG Effect of total parenteral nutrition plus morphine on bacterial translocation in rats. Ann Surg 1993; 217: 286-292. PMID: 8452407
45. Meng J, Yu H, Ma J, Wang J, Banerjee S, Charboneau R, et al. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner. PLoS One 2013; 8: e54040. doi: 10.1371/journal.pone.0054040 PMID: 23349783
46. Nieuwenhuijs VB, Verheem A, van Duijvenbode-Beumer H, Visser MR, Verhoef J, Gooszen HG, et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg 1998; 228: 188-193. PMID: 9712563
47. Biswas SK, Lopez-Collazo E Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009; 30: 475-487. doi: 10.1016/j.it.2009.07.009 PMID: 19781994
48. Bohannon JK, Hernandez A, Enkhbaatar P, Adams WL, Sherwood ER The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Shock 2013; 40: 451-462. doi: 10. 1097/SHK.0000000000000042 PMID: 23989337
49. Foster SL, Hargreaves DC, Medzhitov R Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007; 447: 972-978. PMID: 17538624
50. Fernandez-Botran R, Joshi-Barve S, Ghare S, Barve S, Young M, Plankey M, et al. Systemic Cytokine and Interferon Responsiveness Patterns in HIV and HCV Mono and Co-Infections. J Interferon Cytokine Res 2014.
51. Pedersen KK, Pedersen M, Troseid M, Gaardbo JC, Lund TT, Thomsen C, et al. Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction. J Acquir Immune Defic Syndr 2013; 64: 425-433. doi: 10.1097/QAI.0b013e31829f919d PMID: 23797689
52. Meijerink H, Wisaksana R, Iskandar S, den Heijer M, van der Ven AJ, Alisjahbana B, et al. Injecting drug use is associated with a more rapid CD4 cell decline among treatment naive HIV-positive patients in Indonesia. J Int AIDS Soc 2014; 17: 18844. doi: 10.7448/IAS.17.1.18844 PMID: 24388495
53. Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 1998; 12: 381-388. PMID: 9520167
54. Piroth L, Grappin M, Cuzin L, Mouton Y, Bouchard O, Raffi F, et al. Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients. J Viral Hepat 2000; 7: 302-308. PMID: 10886541
55. Carlos Martin J, Castilla J, Lopez M, Arranz R, Gonzalez-Lahoz J, Soriano V Impact of chronic hepatitis C on HIV-1 disease progression. HIV Clin Trials 2004; 5: 125-131. PMID: 15248136
56. Stebbing J, Waters L, Mandalia S, Bower M, Nelson M, Gazzard B Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events. Clin Infect Dis 2005; 41: 906-911. PMID: 16107994
57. Greub G, Genton B, Safary A, Thoelen S, Frei PC Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix. Vaccine 2000; 19: 1113-1117. PMID: 11137246
58. De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, et al. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 2002; 162: 2125-2132. PMID: 12374521
59. Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB, Canadian Co-infection Cohort Study I Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy. AIDS 2010; 24: 1857-1865. doi: 10.1097/QAD.0b013e32833adbb5 PMID: 20479633
60. Chen TY, Ding EL, Seage Iii GR, Kim AY Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009; 49: 1605-1615. doi: 10.1086/644771 PMID: 19842982
61. Meijerink H, Indrati A, Soedarmo S, Utami F, de Jong CA, Alisjahbana B, et al. Heroin use in Indonesia is associated with higher expression of CCR5 on CD4+ cells and lower ex-vivo production of CCR5 ligands. AIDS 2014.
62. Smith AP, Lee NM Opioid receptor interactions: local and nonlocal, symmetric and asymmetric, physical and functional. Life Sci 2003; 73: 1873-1893. PMID: 12899914
63. Coussons ME, Dykstra LA, Lysle DT Pavlovian conditioning of morphine-induced alterations of immune status. J Neuroimmunol 1992; 39: 219-230. PMID: 1644897
64. Zijlstra F, Veltman DJ, Booij J, van den Brink W, Franken IH Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug Alcohol Depend 2009; 99: 183-192. doi: 10.1016/j.drugalcdep.2008.07.012 PMID: 18823721
65. Regan PM, Dave RS, Datta PK, Khalili K Epigenetics of micro-opioid receptors: intersection with HIV-1 infection of the central nervous system. J Cell Physiol 2012; 227: 2832-2841. doi: 10.1002/jcp.24004 PMID: 22034138